Cluster features in fibrosing interstitial lung disease and associations with prognosis

被引:0
作者
Wang, Yuanying [1 ]
Sun, Di [1 ]
Wang, Jingwei [1 ]
Yu, Shiwen [1 ,2 ]
Wu, Na [1 ,2 ]
Ye, Qiao [1 ,2 ]
机构
[1] Capital Med Univ, Affiliated Beijing Chao Yang Hosp, Beijing Inst Resp Med, Clin Ctr Interstitial Lung Dis, Beijing, Peoples R China
[2] Capital Med Univ, Affiliated Beijing Chao Yang Hosp, Dept Occupat Med & Toxicol, Beijing, Peoples R China
关键词
Pulmonary fibrosis; Interstitial lung diseases; Cluster analysis; Prognosis; Acute exacerbation; IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION; DOUBLE-BLIND; IDENTIFICATION; PIRFENIDONE; DIAGNOSIS; UPDATE;
D O I
10.1186/s12890-023-02735-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management. We aimed to identify associations between clinical characteristics and outcomes in patients with F-ILD.Methods Retrospectively, 575 out of 926 patients with F-ILD were eligible for analysis. Four clusters were identified based on baseline data using cluster analysis. The clinical characteristics and outcomes were compared among the groups.Results Cluster 1 was characterized by a high prevalence of comorbidities and hypoxemia at rest, with the worst lung function at baseline; Cluster 2 by young female patients with less or no smoking history; Cluster 3 by male patients with highest smoking history, the most noticeable signs of velcro crackles and clubbing of fingers, and the severe lung involvement on chest image; Cluster 4 by male patients with a high percentage of occupational or environmental exposure. Clusters 1 (median overall survival [OS] = 7.0 years) and 3 (OS = 5.9 years) had shorter OS than Clusters 2 (OS = not reached, Cluster 1: p < 0.001, Cluster 3: p < 0.001) and 4 (OS = not reached, Cluster 1: p = 0.004, Cluster 3: p < 0.001). Clusters 1 and 3 had a higher cumulative incidence of acute exacerbation than Clusters 2 (Cluster 1: p < 0.001, Cluster 3: p = 0.014) and 4 (Cluster 1: p < 0.001, Cluster 3: p = 0.006). Stratification by using clusters also independently predicted acute exacerbation (p < 0.001) and overall survival (p < 0.001).Conclusions The high degree of disease heterogeneity of F-ILD can be underscored by four clusters based on clinical characteristics, which may be helpful in predicting the risk of fibrosis progression, acute exacerbation and overall survival.
引用
收藏
页数:11
相关论文
共 34 条
  • [21] Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
    Raghu, Ganesh
    Remy-Jardin, Martine
    Richeldi, Luca
    Thomson, Carey C.
    Inoue, Yoshikazu
    Johkoh, Takeshi
    Kreuter, Michael
    Lynch, David A.
    Maher, Toby M.
    Martinez, Fernando J.
    Molina-Molina, Maria
    Myers, Jeffrey L.
    Nicholson, Andrew G.
    Ryerson, Christopher J.
    Strek, Mary E.
    Troy, Lauren K.
    Wijsenbeek, Marlies
    Mammen, Manoj J.
    Hossain, Tanzib
    Bissell, Brittany D.
    Herman, Derrick D.
    Hon, Stephanie M.
    Kheir, Fayez
    Khor, Yet H.
    Macrea, Madalina
    Antoniou, Katerina M.
    Bouros, Demosthenes
    Buendia-Roldan, Ivette
    Caro, Fabian
    Crestani, Bruno
    Ho, Lawrence
    Morisset, Julie
    Olson, Amy L.
    Podolanczuk, Anna
    Poletti, Venerino
    Selman, Moises
    Ewing, Thomas
    Jones, Stephen
    Knight, Shandra L.
    Ghazipura, Marya
    Wilson, Kevin C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (09) : E18 - E47
  • [22] Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
    Raghu, Ganesh
    Remy-Jardin, Martine
    Myers, Jeffrey L.
    Richeldi, Luca
    Ryerson, Christopher J.
    Lederer, David J.
    Behr, Juergen
    Cottin, Vincent
    Danoff, Sonye K.
    Morell, Ferran
    Flaherty, Kevin R.
    Wells, Athol
    Martinez, Fernando J.
    Azuma, Arata
    Bice, Thomas J.
    Bouros, Demosthenes
    Brown, Kevin K.
    Collard, Harold R.
    Duggal, Abhijit
    Galvin, Liam
    Inoue, Yoshikazu
    Jenkins, R. Gisli
    Johkoh, Takeshi
    Kazerooni, Ella A.
    Kitaichi, Masanori
    Knight, Shandra L.
    Mansour, George
    Nicholson, Andrew G.
    Pipavath, Sudhakar N. J.
    Buendia-Roldan, Ivette
    Selman, Moises
    Travis, William D.
    Walsh, Simon
    Wilson, Kevin C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (05) : E44 - E68
  • [23] Interstitial lung disease and diabetes
    Rajasurya, Venkat
    Gunasekaran, Kulothungan
    Surani, Salim
    [J]. WORLD JOURNAL OF DIABETES, 2020, 11 (08)
  • [24] Predicting Survival Across Chronic Interstitial Lung Disease The ILD-GAP Model
    Ryerson, Christopher J.
    Vittinghoff, Eric
    Ley, Brett
    Lee, Joyce S.
    Mooney, Joshua J.
    Jones, Kirk D.
    Elicker, Brett M.
    Wolters, Paul J.
    Koth, Laura L.
    King, Talmadge E., Jr.
    Collard, Harold R.
    [J]. CHEST, 2014, 145 (04) : 723 - 728
  • [25] Identification of Clinical Phenotypes in Idiopathic Interstitial Pneumonia with Pulmonary Emphysema
    Sato, Suguru
    Tanino, Yoshinori
    Misa, Kenichi
    Fukuhara, Naoko
    Nikaido, Takefumi
    Uematsu, Manabu
    Fukuhara, Atsuro
    Wang, Xintao
    Ishida, Takashi
    Munakata, Mitsuru
    [J]. INTERNAL MEDICINE, 2016, 55 (12) : 1529 - 1535
  • [26] Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
    Schimmelpennink, M. C.
    Meek, D. B.
    Vorselaars, A. D. M.
    Langezaal, L. C. M.
    van Moorsel, C. H. M.
    van der Vis, J. J.
    Veltkamp, M.
    Grutters, J. C.
    [J]. RESPIRATORY RESEARCH, 2022, 23 (01)
  • [27] Acute exacerbations of fibrotic interstitial lung diseases
    Suzuki, Atsushi
    Kondoh, Yasuhiro
    Brown, Kevin K.
    Johkoh, Takeshi
    Kataoka, Kensuke
    Fukuoka, Junya
    Kimura, Tomoki
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Fukihara, Jun
    Ando, Masahiko
    Tanaka, Tomonori
    Hashimoto, Naozumi
    Sakamoto, Koji
    Hasegawa, Yoshinori
    [J]. RESPIROLOGY, 2020, 25 (05) : 525 - 534
  • [28] An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
    Travis, William D.
    Costabel, Ulrich
    Hansell, David M.
    King, Talmadge E.
    Lynch, David A.
    Nicholson, Andrew G.
    Ryerson, Christopher J.
    Ryu, Jay H.
    Selman, Moises
    Wells, Athol U.
    Behr, Jurgen
    Bouros, Demosthenes
    Brown, Kevin K.
    Colby, Thomas V.
    Collard, Harold R.
    Cordeiro, Carlos Robalo
    Cottin, Vincent
    Crestani, Bruno
    Drent, Marjolein
    Dudden, Rosalind F.
    Egan, Jim
    Flaherty, Kevin
    Hogaboam, Cory
    Inoue, Yoshikazu
    Johkoh, Takeshi
    Kim, Dong Soon
    Kitaichi, Masanori
    Loyd, James
    Martinez, Fernando J.
    Myers, Jeffrey
    Protzko, Shandra
    Raghu, Ganesh
    Richeldi, Luca
    Sverzellati, Nicola
    Swigris, Jeffrey
    Valeyre, Dominique
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (06) : 733 - 748
  • [29] Role of imaging in progressive-fibrosing interstitial lung diseases
    Walsh, Simon L. F.
    Devaraj, Anand
    Enghelmayer, Juan Ignacio
    Kishi, Kazuma
    Silva, Rafael S.
    Patel, Nina
    Rossman, Milton D.
    Valenzuela, Claudia
    Vancheri, Carlo
    [J]. EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150)
  • [30] Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies
    Wongkarnjana, Amornpun
    Scallan, Ciaran
    Kolb, Martin R. J.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 436 - 442